Our Work

We are inspired by companies, researchers and entrepreneurs who want to make a true difference

We work with great clients and great people. Catalyze supports a variety of Life Sciences developments including, but not limited to, diagnostics, pharmaceuticals, medical devices and healthcare solutions. Our clients range from researchers at academic hospitals and universities, to non-profit organizations, start-ups, SMEs and larger companies. This includes clients who focus on their own product development, but also strong partnerships with the services industry like CROs, formulation partners, clinical trials experts and regulatory experts.

View some example cases

 

TRiCares

TRiCares

TRiCares, a French-German medical device company, has been awarded a prestigious Horizon 2020 SME Instrument Phase 2 grant to bring the unique heart valve replacement system to clinical readiness.

REACTION!

REACTION!

The REACTION! Project comprises a direct-aid response to the EBOLA crisis in 2015. The project was initiated by an international project team to provide rapid aid and health-care to the Ebola-infected population in Guinea, and by directly collecting rapid evidence of the efficacy of Favipiravir in reducing the mortality and Ebola viral load in the…

SkylineDx; novel gene-expression profiling technology

SkylineDx; novel gene-expression profiling technology

SkylineDx has been awarded a multi-million euro Horizon2020 grant from the European Commission to develop a new, and novel gene-expression profiling technology, which is intended to predict the most effective treatment strategy for patients with multiple myeloma (MM).

INCISION Academy next step towards universal surgical language

INCISION Academy next step towards universal surgical language

The SurgASSIST project aims to improve surgical care by changing the way surgeons are educated. The SurgASSIST project provides an online educational program, the INCISION Academy, that uses 3D visualizations (stereoscopic videos and animations) to teach surgical procedures step-by-step, based on state-of-the-art scientific research and best-practice surgical care.

Novel drug delivery method for DR patients

Novel drug delivery method for DR patients

PREVIN combines a novel drug delivery method to treat patients with Diabetic Retinopathy (DR) (i.e. blindness in Diabetes patients) with established drugs.

Perceive 3D presents a new concept of video based intra-operative navigation

Perceive 3D presents a new concept of video based intra-operative navigation

Perceive3D has received a prestigious €1.3 EU million grant from the Horizon 2020 SME Instrument Phase 2 funding to develop in.nav. In.nav is the first system for intra-operative navigation based on video.

ESCAPE-NET project aims to improve SCA management

ESCAPE-NET project aims to improve SCA management

Sudden cardiac arrest (SCA) causes ~20% of all deaths in Europe. SCA is lethal within minutes if left untreated and survival rates are presently only 5-20%. Therefore, there is a large medical need to improve SCA prevention and treatment.

Epithydia proposal ranks 1st out of 300 in Eurostars application

Epithydia proposal ranks 1st out of 300 in Eurostars application

The grant proposal written by Catalyze for the Epithydia project ranked 1st out of 300 applications.

 

Welcome at Catalyze!

Catalyze uses cookies in order to improve your user experience. By using this website you agree to our policy.

Go back or